Cutaneous Metastases and Long-Term Survival of a Patient With Clear Cell Renal Carcinoma

被引：4

作者：

Vilaca, Marta ^{[1
]}

Braga, Fatima ^{[1
]}

Mesquita, Alexandra ^{[1
]}

机构：

[1] Hosp Pedro Hispano, Oncol, Matosinhos, Portugal

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 03期

关键词：

long-term survival; target therapy; predictors of response; cutaneous metastasis; metastatic renal cell carcinoma; KIDNEY CANCER; EVEROLIMUS; SUNITINIB; BIOMARKER; AXITINIB; EFFICACY;

D O I：

10.7759/cureus.23598

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The treatment landscape of metastatic renal cell carcinoma (mRCC) has changed in the last decade with improvements in overall survival. Overall survival ranges from 57 months in good-to-intermediate prognosis patients to 19 months in poor prognosis patients. The most frequent sites of metastasis are the lungs, bone, distant lymph nodes, liver, adrenal, and brain. Cutaneous metastases are rare and represent an end-stage disease with a worse prognosis. Studying long-term survivors of mRCC can help clinicians to identify potential predictors of response to targeted therapy and define the hest treatment sequences in this setting. hi this case, we report a 59-year-old man with a good mRCC prognosis who is alive 156 months after the diagnosis of mRCC, 108 months with cutaneous metastases. The patient underwent five treatment lines, with good tolerance and quality of life. This therapeutic sequence was based on new treatment options and new evidence concerning mRCC.

引用

页数：6

共 20 条

[11] Systemic Light Chain Amyloidosis, Version 2.2023 [J].

Kumar, Shaji K. ;

Callander, Natalie S. ;

Adekola, Kehinde ;

Anderson, Larry D., Jr. ;

Baljevic, Muhamed ;

Campagnaro, Erica ;

Castillo, Jorge J. ;

Costello, Caitlin ;

D'Angelo, Christopher ;

Devarakonda, Srinivas ;

Elsedawy, Noura ;

Garfall, Alfred ;

Godby, Kelly ;

Hillengass, Jens ;

Holmberg, Leona ;

Htut, Myo ;

Huff, Carol Ann ;

Hultcrantz, Malin ;

Kang, Yubin ;

Larson, Sarah ;

Lee, Hans C. ;

Liedtke, Michaela ;

Martin, Thomas ;

Omel, James ;

Rosenberg, Aaron ;

Sborov, Douglas ;

Valent, Jason ;

Berardi, Ryan ;

Kumar, Rashmi .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01) :67-81

[12] Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors [J].

Motzer, Robert J. ;

Escudier, Bernard ;

Oudard, Stephane ;

Hutson, Thomas E. ;

Porta, Camillo ;

Bracarda, Sergio ;

Grunwald, Viktor ;

Thompson, John A. ;

Figlin, Robert A. ;

Hollaender, Norbert ;

Kay, Andrea ;

Ravaud, Alain .

CANCER, 2010, 116 (18) :4256-4265

[13] Cutaneous metastases in renal cell carcinoma: a systematic review and a case report [J].

Ohlsson, Rikard ;

Geertsen, Louise ;

Berge Stuveseth, Stine ;

Lund, Lars .

SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 (01) :9-13

[14]

Paule B, 2011, ANTICANCER RES, V31, P3507

[15] Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial [J].

Rini, Brian I. ;

Escudier, Bernard ;

Tomczak, Piotr ;

Kaprin, Andrey ;

Szczylik, Cezary ;

Hutson, Thomas E. ;

Michaelson, M. Dror ;

Gorbunova, Vera A. ;

Gore, Martin E. ;

Rusakov, Igor G. ;

Negrier, Sylvie ;

Ou, Yen-Chuan ;

Castellano, Daniel ;

Lim, Ho Yeong ;

Uemura, Hirotsugu ;

Tarazi, Jamal ;

Cella, David ;

Chen, Connie ;

Rosbrook, Brad ;

Kim, Sinil ;

Motzer, Robert J. .

LANCET, 2011, 378 (9807) :1931-1939

[16] Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors [J].

Rini, Brian I. ;

Schiller, Joan H. ;

Fruehauf, John P. ;

Cohen, Ezra E. W. ;

Tarazi, Jamal C. ;

Rosbrook, Brad ;

Bair, Angel H. ;

Ricart, Alejandro D. ;

Olszanski, Anthony J. ;

Letrent, Kristen J. ;

Kim, Sinil ;

Rixe, Olivier .

CLINICAL CANCER RESEARCH, 2011, 17 (11) :3841-3849

[17] Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib [J].

Rini, Brian I. ;

Cohen, Darrel P. ;

Lu, Dongrui R. ;

Chen, Isan ;

Hariharan, Subramanian ;

Gore, Martin E. ;

Figlin, Robert A. ;

Baum, Michael S. ;

Motzer, Robert J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (09) :763-773

[18] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].

Sung, Hyuna ;

Ferlay, Jacques ;

Siegel, Rebecca L. ;

Laversanne, Mathieu ;

Soerjomataram, Isabelle ;

Jemal, Ahmedin ;

Bray, Freddie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249

[19] Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients [J].

Voog, Eric ;

Campillo-Gimenez, Boris ;

Elkouri, Claude ;

Priou, Franck ;

Rolland, Frederic ;

Laguerre, Brigitte ;

Elhannani, Chaza ;

Merrer, Jacques ;

Pfister, Christian ;

Sevin, Emmanuel ;

L'Haridon, Tifenn ;

Hasbini, Ali ;

Moise, Laura ;

Le Rol, Annick ;

Malhaire, Jean Pierre ;

Delva, Remy ;

Vauleon, Elodie ;

Cojocarasu, Oana ;

Deguiral, Philippe ;

Cumin, Isabelle ;

Cheneau, Caroline ;

Schlurmann, Friedrike ;

Delecroix, Valerie ;

Boughalem, Elouen ;

Mollon, Delphine ;

Ligeza-Poisson, Catherine ;

Abadie-Lacourtoisie, Sophie ;

Monpetit, Erik ;

Chatellier, Thierry ;

Desclos, Henry ;

Coquan, Elodie ;

Joly, Florence ;

Tessereau, Jean Yves ;

Dupuy, Sandra ;

Lagadec, Delphine Deniel ;

Marhuenda, Fanny ;

Grude, Francoise .

INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (06) :1643-1651

[20] Contemporary treatment of metastatic renal cell carcinoma [J].

Wiechno, Pawel ;

Kucharz, Jakub ;

Sadowska, Malgorzata ;

Michalski, Wojciech ;

Sikora-Kupis, Bozena ;

Jonska-Gmyrek, Joanna ;

Poniatowska, Grazyna ;

Nietupski, Karol ;

Ossolinski, Krzysztof ;

Demkow, Tomasz .

MEDICAL ONCOLOGY, 2018, 35 (12)

← 1 2 →